Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Filana Therapeutics's enterprise value was -$59.39M on Nov 11, 2026, against $50.92M a year earlier. Over the last 5 years it ranged from -$59.39M to $1.53B, with a median of $710.61M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$59.39M | – |
| 2025 | Dec 31, 2025 | -$10.43M | – |
| 2024 | Dec 31, 2024 | -$35.75M | -104.4% |
| 2023 | Dec 29, 2023 | $805.99M | -20.1% |
| 2022 | Dec 30, 2022 | $1.01B | -33.1% |
| 2021 | Dec 31, 2021 | $1.51B | +902.3% |
| 2020 | Dec 31, 2020 | $150.37M | +109.6% |
| 2019 | Dec 31, 2019 | $71.74M | – |
| 2018 | Dec 31, 2018 | -$5.81M | -140.1% |
| 2017 | Dec 29, 2017 | $14.47M | +218.2% |
| 2016 | Dec 30, 2016 | $4.55M | -89.8% |
| 2015 | Dec 31, 2015 | $44.48M | -9.2% |
| 2014 | Dec 31, 2014 | $49.00M | -70.7% |
| 2013 | Dec 31, 2013 | $167.52M | +100.8% |
| 2012 | Apr 30, 2012 | $83.44M | -27.8% |
| 2011 | Jul 29, 2011 | $115.60M | – |
See a number that looks wrong?